Circulating Tumor Cell Analysis in Patients with Progressive Castration-Resistant Prostate Cancer

Abstract

The analysis of cancer-related alterations at the DNA and protein level from CTCs is feasible in a hospital-based clinical laboratory. The alterations observed in EGFR and AR suggest that the methodology may have a role in clinical decision making.